open access

Vol 10, No 2 (2015)
Young Cardiology
Published online: 2015-05-22
Get Citation

Surgically treated cardiac masses — a single-centre experience

Kamil Michta, Edward Pietrzyk, Beata Wożakowska-Kapłon
DOI: 10.5603/FC.2015.0018
·
Folia Cardiologica 2015;10(2):86-90.

open access

Vol 10, No 2 (2015)
Young Cardiology
Published online: 2015-05-22

Abstract

Introduction. Cardiac masses may be of neoplastic or non-neoplastic nature. The most common benign primary cardiac tumour is myxoma, and the most common malignant tumour is sarcoma. Metastatic tumours are more prevalent than primary cardiac tumours. Surgical excision of the cardiac mass is the treatment of choice. The aim of this study was to evaluate the prevalence of specific types of cardiac masses and their effect on outcomes in surgically treated patients with cardiac masses.

Material and methods. We studied all patients treated at the Department of Cardiac Surgery, Świętokrzyskie Cardiology Centre in Kielce, with the echocardiographic diagnosis of a cardiac mass who were operated in 2008–2014.

Results. Our study group included 19 patients aged 25 to 80 years (mean age 60.8 years). Based on histologic evaluation of the resected mass, myxoma was diagnosed in 13 patients (68.4%), thrombus in 4 patients (21.1%), lipoma in one patient (5.3%), and metastatic right adrenal tumour in one patient (5.3%). The mass was most commonly located in the left atrium (n = 13, 68.4%), followed by the left ventricle and right atrium (n = 2 each, 10.5%), and the right ventricle and both atria (n = 1 each, 5.3%). Three patients (16%) died in the early postoperative period, and all 16 patients who were discharged from the Department of Cardiac Surgery were alive at long-term follow-up (mean 2.5 years).

Conclusions. Surgical excision is the treatment of choice in patients with cardiac masses, except for those in whom the tumour is a manifestation of an advanced neoplastic disease. Long-term outcomes in patients operated due to a cardiac mass are favourable.  

Abstract

Introduction. Cardiac masses may be of neoplastic or non-neoplastic nature. The most common benign primary cardiac tumour is myxoma, and the most common malignant tumour is sarcoma. Metastatic tumours are more prevalent than primary cardiac tumours. Surgical excision of the cardiac mass is the treatment of choice. The aim of this study was to evaluate the prevalence of specific types of cardiac masses and their effect on outcomes in surgically treated patients with cardiac masses.

Material and methods. We studied all patients treated at the Department of Cardiac Surgery, Świętokrzyskie Cardiology Centre in Kielce, with the echocardiographic diagnosis of a cardiac mass who were operated in 2008–2014.

Results. Our study group included 19 patients aged 25 to 80 years (mean age 60.8 years). Based on histologic evaluation of the resected mass, myxoma was diagnosed in 13 patients (68.4%), thrombus in 4 patients (21.1%), lipoma in one patient (5.3%), and metastatic right adrenal tumour in one patient (5.3%). The mass was most commonly located in the left atrium (n = 13, 68.4%), followed by the left ventricle and right atrium (n = 2 each, 10.5%), and the right ventricle and both atria (n = 1 each, 5.3%). Three patients (16%) died in the early postoperative period, and all 16 patients who were discharged from the Department of Cardiac Surgery were alive at long-term follow-up (mean 2.5 years).

Conclusions. Surgical excision is the treatment of choice in patients with cardiac masses, except for those in whom the tumour is a manifestation of an advanced neoplastic disease. Long-term outcomes in patients operated due to a cardiac mass are favourable.  

Get Citation

Keywords

cardiac masses, myxoma, left atrial mass

About this article
Title

Surgically treated cardiac masses — a single-centre experience

Journal

Folia Cardiologica

Issue

Vol 10, No 2 (2015)

Pages

86-90

Published online

2015-05-22

DOI

10.5603/FC.2015.0018

Bibliographic record

Folia Cardiologica 2015;10(2):86-90.

Keywords

cardiac masses
myxoma
left atrial mass

Authors

Kamil Michta
Edward Pietrzyk
Beata Wożakowska-Kapłon

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl